Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+690K
-
Total reported value, excl. options
-
$1.82B
-
Value change
-
+$18.2M
-
Put/Call ratio
-
0.08
-
Number of buys
-
61
-
Number of sells
-
-68
-
Price
-
$16.45
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2017
163 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2017.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 363M outstanding shares and own 30.43% of the company stock.
Largest 10 shareholders include Artal Group S.A. (57.5M shares), FMR LLC (15.8M shares), BlackRock Inc. (4.66M shares), UBS ASSET MANAGEMENT AMERICAS INC (3.81M shares), VANGUARD GROUP INC (3.71M shares), USS Investment Management Ltd (3.51M shares), EAGLE ASSET MANAGEMENT INC (2.86M shares), NEA Management Company, LLC (2.38M shares), STATE STREET CORP (1.97M shares), and NORGES BANK (1.11M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.